Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis

NEXT STORY
BioSig Appoints John W. Osborn, Ph.D. as Consultant on Autonomic Neuromodulation
PREV STORY
Matinas BioPharma Appoints James A. Underberg, M.D. to its MAT9001 Scientific Advisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenahealth’s Nationwide Network Delivers Data Insights that Contribute to Country’s Real-Time Learning and Response to COVID-19 Pandemic

author_avatar
NASDAQ Market News

Loxo Oncology Announces FDA Orphan Drug Designation Granted to Larotrectinib for the Treatment of Solid Tumors with NTRK-Fusion Proteins

STAMFORD, Conn., May 12, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

TVO Supports Students, Educators and Parents During Back-to-School

author_avatar
NASDAQ Market News